MedTrace Logo

Clinical Study on a Novel Anti-adhesion Barrier Film

NCT05888545 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1176

Last updated 2024-02-23

No results posted yet for this study

Summary

The aim of this clinical study was to verify the effectiveness and safety of the anti-adhesion diaphragm in preventing intrauterine adhesions.

Conditions

  • Intrauterine Adhesion

Interventions

DEVICE

anti-adhesion diaphragm

Participants will be asked to place an anti-adhesion diaphragm in the uterus for 3-7 days after the abortion procedure.

Sponsors & Collaborators

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine

    lead OTHER

Principal Investigators

  • Jian Xu, PhD · The Fourth Affiliated Hospital Zhejiang University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-12-01
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888545 on ClinicalTrials.gov